In a new study, researchers identify the biological processes behind stress-induced aversive memory generalization and highlight an intervention which could help restore appropriate memory specificity ...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...
a clinical-stage biopharmaceutical company, focuses on developing novel treatments for brain health disorders, utilizing innovative approaches to enhance patient outcomes. The company’s latest ...